Amphastar Pharma (AMPH) Tops Q1 EPS by 2c

Amphastar Pharma (NASDAQ: AMPH) reported Q1 EPS of $0.09, $0.02 better than the analyst estimate of $0.07. Revenue for the quarter came in at $56.67 million versus the consensus estimate of $19.49 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

You May Also Be Interested In

• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
• AI and earnings keep driving markets as focus shifts to Trump-Xi summit
• Thor Industries (THO) Misses Q4 EPS by 13c